Kidney Neoplasm
📧 Sign up to get email alerts when something new happens for Kidney Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry
The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry is currently recruiting to study management strategies fo…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors [Phase 2]
A Phase 2 clinical trial is evaluating hyperpolarized 13C pyruvate MRI as a biomarker to predict aggressiveness of renal tumors. The study i…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: German National Registry for NSS
A German national registry for nephron-sparing surgery (NSS) in kidney neoplasms is currently recruiting, sponsored by the Association of Ur…
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating an individualized treatment strategy for patients with metastatic non-clear cell renal cell carcinoma is ongoing, s…
-
CLINICAL_TRIALS trial_result · 2018-11-28Clinical Trial Update: Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250 [Phase 1]
Phase 1 trial evaluating a radiolabeled antibody with Yttrium-90 for advanced renal cancer has completed, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: [18F]Fluciclatide PET Imaging of Pazopanib Response [Phase 2]
Phase 2 trial using [18F]Fluciclatide PET imaging to assess Pazopanib response in kidney neoplasms has been terminated.